| Income statement (USD) | Q4 2026 ended Jun 30, 2026 | Q3 2026 ended Mar 31, 2026 | Q2 2026 ended Dec 31, 2025 | Q1 2026 ended Sep 30, 2025 | Q4 2025 ended Jun 30, 2025 | Q3 2025 ended Mar 31, 2025 | Q2 2025 ended Dec 31, 2024 | Q1 2025 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 12.0K | 74.0K | ||||
| Research and development | 1.49M | 321.0K | 2.28M | 1.12M | 3.70M | 2.73M | 1.41M | 2.90M |
| Operating expenses | 5.19M | 4.05M | 7.00M | 6.79M | 7.53M | 5.00M | 5.02M | 6.33M |
| Operating income | -5.19M | -4.05M | -7.00M | -6.79M | -7.53M | -5.00M | -5.00M | -6.25M |
| EBITDA | -5.14M | -3.98M | -6.94M | -6.73M | -7.47M | -5.01M | -4.80M | -6.19M |
| Interest expense | -5.0K | -5.0K | 0 | 132.0K | -28.0K | -28.0K | ||
| Income before tax | -2.49M | -3.88M | -6.52M | -6.41M | -31.60M | -3.97M | -5.89M | -5.42M |
| Net income | -2.49M | -3.88M | -6.52M | -6.41M | -31.60M | -3.97M | -5.89M | -5.42M |
| EPS | -0.15 | -0.35 | -0.02 | -0.02 | -15.43 | -6.19 | -0.33 | -0.29 |
| EPS (diluted) | -0.15 | -0.35 | -0.02 | -0.02 | -15.43 | -6.19 | -0.33 | -0.29 |
| Diluted shares | 207.1K | 12.35M | 349.46M | 310.31M | 540.5K | 654.4K | 17.62M | 17.64M |
From Incannex Healthcare Inc.'s 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.